0001062993-20-006253.txt : 20201211
0001062993-20-006253.hdr.sgml : 20201211
20201211165100
ACCESSION NUMBER: 0001062993-20-006253
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201209
FILED AS OF DATE: 20201211
DATE AS OF CHANGE: 20201211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Banks Jerel A.
CENTRAL INDEX KEY: 0001808930
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39267
FILM NUMBER: 201384039
MAIL ADDRESS:
STREET 1: LEVEL 14, 114 WILLIAM ST
CITY: MELBOURNE, VIC
STATE: C3
ZIP: 3000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Benitec Biopharma Inc.
CENTRAL INDEX KEY: 0001808898
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: LEVEL 14, 114 WILLIAM ST
CITY: MELBOURNE, VIC
STATE: C3
ZIP: 3000
BUSINESS PHONE: 61(0)3 8692-7222
MAIL ADDRESS:
STREET 1: LEVEL 14, 114 WILLIAM ST
CITY: MELBOURNE, VIC
STATE: C3
ZIP: 3000
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2020-12-09
0001808898
Benitec Biopharma Inc.
BNTC
0001808930
Banks Jerel A.
C/O BENITEC BIOPHARMA INC.
3940 TRUST WAY
HAYWARD
CA
94545
1
1
0
0
Chief Executive Officer
Options (right to buy)
2.98
2020-12-09
4
A
0
284345
0
A
2030-12-09
Common Stock
284345
284345
D
The stock options will vest in three substantially equal installments on December 9, 2021, December 9, 2022, and December 9, 2023.
/s/ Jerel A. Banks
2020-12-11